Parallel Advisors’s Fulgent Genetics FLGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.2K | Buy |
1,118
+162
| +17% | +$3.22K | ﹤0.01% | 2130 |
|
|
2025
Q1 | $16.2K | Buy |
956
+654
| +217% | +$11.1K | ﹤0.01% | 2230 |
|
|
2024
Q4 | $5.58K | Buy |
302
+177
| +142% | +$3.27K | ﹤0.01% | 2576 |
|
|
2024
Q3 | $2.72K | Hold |
125
| – | – | ﹤0.01% | 2782 |
|
|
2024
Q2 | $2.45K | Sell |
125
-68
| -35% | -$1.33K | ﹤0.01% | 2737 |
|
|
2024
Q1 | $4.19K | Buy |
193
+46
| +31% | +$998 | ﹤0.01% | 2585 |
|
|
2023
Q4 | $4.25K | Buy |
147
+26
| +21% | +$752 | ﹤0.01% | 2574 |
|
|
2023
Q3 | $3.24K | Sell |
121
-109
| -47% | -$2.92K | ﹤0.01% | 2660 |
|
|
2023
Q2 | $8.52K | Sell |
230
-1
| -0.4% | -$37 | ﹤0.01% | 2240 |
|
|
2023
Q1 | $7.21K | Buy |
231
+6
| +3% | +$187 | ﹤0.01% | 2271 |
|
|
2022
Q4 | $6.7K | Sell |
225
-8
| -3% | -$238 | ﹤0.01% | 2198 |
|
|
2022
Q3 | $9K | Sell |
233
-19
| -8% | -$734 | ﹤0.01% | 2013 |
|
|
2022
Q2 | $14K | Sell |
252
-70
| -22% | -$3.89K | ﹤0.01% | 1820 |
|
|
2022
Q1 | $20K | Sell |
322
-339
| -51% | -$21.1K | ﹤0.01% | 1701 |
|
|
2021
Q4 | $66K | Sell |
661
-112
| -14% | -$11.2K | ﹤0.01% | 1174 |
|
|
2021
Q3 | $70K | Sell |
773
-100
| -11% | -$9.06K | ﹤0.01% | 1115 |
|
|
2021
Q2 | $81K | Sell |
873
-391
| -31% | -$36.3K | ﹤0.01% | 1006 |
|
|
2021
Q1 | $122K | Buy |
+1,264
| New | +$122K | 0.01% | 802 |
|